Pune: Serum Institute of India CEO Adar Poonawalla is expecting approval for COVID-19 vaccine by end of December, while the vaccination drive in the country could start by next month. ...
New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once ...
New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs Controller General ...
The clinical trials of the COVID-19 vaccine candidate being developed by Oxford University and AstraZeneca may have been put on pause following an adverse reaction observed in one of the ...
New Delhi: An expert committee at the apex drug regulator, Central Drugs Standards Control Organisation (CDSCO) has deferred its earlier call on Serum Institute of India Pvt Ltd’s vaccine trial. ...
New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune. The vaccine ...
New Delhi: The Department of Biotechnology (DBT) will provide funds to three companies, Cadila Healthcare Ltd (Zydus Cadila), Bharat Biotech International Ltd and Serum Institute of India Private Limited. to ...